Connecting Cohorts to Diminish Alzheimer’s Disease (CONCORD-AD): A report of an International Research Collaboration Network

Manuscript Number: 

21-0525R1

Author(s): 
Samantha C. Burnham, Lesley M. Butler, Preciosa M. Coloma, Jean-François Dartigues, Rachelle S. Doody, Oskar Hansson, Catherine Helmer, Joseph S. Kass, Colin L. Masters, Sebastian Palmqvist, Valory Pavlik, Karine Peres, Ronald C. Petersen, Mary Sano, Erik Stomrud, Xavier Teitsma, Maria Vassilaki

Disclosures

Samantha C. Burnham

  • Patents/Royalties
    Method for detection of a neurological disease: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=5KxzR2EAAAAJ&cstart=100&pagesize=100&sortby=pubdate&citation_for_view=5KxzR2EAAAAJ:LgRImbQfgY4C SC Burnham, N Faux, SM Laws US Patent App. 14/116,114

Lesley M. Butler

  • Sponsors:
    Employee of F. Hoffmann-La Roche Ltd.

Preciosa M. Coloma

  • Sponsors:
    Employee of F. Hoffmann-La Roche Ltd.

Jean-François Dartigues

  • Nothing to Disclose

Rachelle S. Doody

  • Equity:
    Owns stock in F. Hoffmann-La Roche Ltd.
    Sponsors:
    Employee of Genentech Inc., part of F. Hoffmann-La Roche, Ltd.

Oskar Hansson

  • Grants
    • Agency: 
      F. Hoffmann-La Roche
      Dates: 
      Jan 1, 2018
    • Agency: 
      Pfizer
      Dates: 
      Jan 1, 2017
    • Agency: 
      GE Healthcare
      Dates: 
      Jan 1, 2018
    • Agency: 
      Biogen
      Dates: 
      Dec 1, 2020
    • Agency: 
      AVID Radiopharmaceuticals
      Dates: 
      Jan 1 2014
    • Agency: 
      Euroimmun
      Dates: 
      Jan 1, 2016

Catherine Helmer

  • Nothing to Disclose

Joseph S. Kass

  • Nothing to Disclose

Colin L. Masters

  • Nothing to Disclose

Sebastian Palmqvist

  • Nothing to Disclose

Valory Pavlik

  • Nothing to Disclose

Karine Peres

  • Nothing to Disclose

Ronald C. Petersen

  • Consulting Fees:
    Consultant for Roche, Inc., Merck, Inc., Biogen, Inc., Eisai, inc. and has served on a DSMB for Genentech, Inc.
    Patents/Royalties
    Receives royalties from Oxford University Press and UpToDate.

Mary Sano

  • Nothing to Disclose

Erik Stomrud

  • Nothing to Disclose

Xavier Teitsma

  • Sponsors:
    Employee of F. Hoffmann-La Roche Ltd.

Maria Vassilaki

  • Consulting Fees:
    currently consult for F. Hoffmann-La Roche on analysis of data and interpretation (started 01/2021), and have received up to the present $4900; payments are submitted to my institution.
    Equity:
    Equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic, and Amgen
    Grants
    • Agency: 
      Biogen
      Dates: 
      12/01/2017 -9/29/2020
    • Agency: 
      F. Hoffmann-La Roche
      Dates: 
      07/01/2016-05/31/2020